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monitoring procedure is highly-efficient. Also, the establishment of stan-
dards of testing specimen can avoid contamination.
Conclusions: Most departments are highly satisfied with the program
because of increased work efficiency. In future, this program can be consid-
ered to contribute to inspect test results of epidemic outbreak and do ‘qual-
ity assurance’ of the medical practice directly related to infection control as
well as consistent monitoring will be needed.PS 2-330
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Purpose: The purpose of this study was to establish a CVBSI Bundles Informa-
tion System which composes the idea of integrated prevent Central Line-
Associated Bloodstream Infections. And constructed a convenience for elec-
tronic documentation, data storage, benefit evaluation and a platform from
medical team member communication.
Methods: CVBSI Bundles Information System was based on the hospital infor-
mation system (HIS) and constructed into 5 pages, there could print pa-
tients’ care information out from the system and reduce duplication
writing. All the hospital ICN was in-charge central line management. Statis-
tical analysis of the system function could be used as basis for assessing the
quality of related work.
Results: Compare to last year, daily assessment and maintenance of central
lines adherence rate were increased from 48.5% to 90.9% and 22.9% to 86.4%,
Central Line-Associated Bloodstream Infection rate was decreased\ from
4.8&to 3.0&, cost down 621,720NT$.
Conclusions: CVBSI Bundles Information System did simplify the operation
and handwritten medical records, reduce the Central Line-Associated
Bloodstream infections rate and cost down.PS 2-331
THE VIRULENCE EFFECT CAUSED BY WZI GENE IN KLEBSIELLA
PNEUMONIAE
Li-Yueh Huang a, Fei-Hsu Chen b, Jen-Chang Chang a, Yu-Kuo Tsai a,
Ci-Hong Liou c, Ling Ma a, Fu-Mei Lin a, Yi-Jiun Ding a, Pei-Jing Chen a,
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Purpose: Klebsiella pneumoniae (Kp) is a well-known pathogen and a com-
mon reason of community-acquired and nosocomial infections causing liver
abscesses, endophthalmitis, or meningitis. Capsular polysaccharide (CPS) is
one of the most important virulent factors in Kp. The virulence effect caused
by wzi gene that is involved in the attachment of the repeat unit of CPS to
outer membrane remains uncertain. Previous studies indicate that deduced
Wzi protein sequence is corresponding to capsular serotype (K-type). This
study aimed to examine the gene actual effect on virulence and its changes
associated with K-type switch.
Methods: In-frame deletion and replacement was used to obtain the dele-
tion and switched mutants of the wzi gene in Kp strain 312, which isolated
from liver abscess patient and harbored K20 CPS cluster. The wzi gene of
switched mutant was replaced from K20-type to K1-type. The virulence
was assessed through serum killing, neutrophil phagocytosis and mouse
lethality assay.
Results: Comparison to the parental 312 strain (K20, serum-sensitive, phago-
cytosis-resistant, LD50Z10
2 cfu), 312D wzi mutant decreased 102-fold ofLD50 and exhibited more susceptible in serum killing and phagocytosis.
LD50 of 312D wzi::K1-wzimutant was 10
3 cfu and there was no significant dif-
ference in virulence assay between 312D wzi and 312D wzi::K1-wzi strains.
Conclusions: The study demonstrates that wzi gene has impact in virulence
in mice model, and contributes to serum killing and phagocytosis of Kp
strains. Furthermore, replacement of distinct K-type wzi gene can also influ-
ence the mice lethality.PS 2-332
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Purpose: Klebsiella pneumoniae carbapenemase (KPC) is one of the most
common carbapenemases. KPC-2-containing K. pneumoniae with sequence
type (ST) 258 and ST 11 clones have been the most worldwide spread. We
report a patient with two KPC new variants (KPC-17 and KPC-22) recovered
from a patient in a nursing home.
Case report
An 86 year-old woman had stayed in a nursing home for 5 month. She was
admitted to the hospital due to acute delirium on March 21, 2014. Brain CT
showed mild cerebral atrophy. Laboratory data showed hemogram, 10.5 g/
dL; WBC, 14,900/mL; CRP, 63.9 mg/L; and creatinine, 2.8 mg/dL. CXR
showed mild bronchiectasis with probably superimposed infection. Empirical
antibiotic was ceftazidime. The sputum culture yielded mixed normal flora.
The blood and urine cultures showed no growth. However, CRP rose to 114.0
mg/L on March 31. Fosfomycin was added. The blood and sputum cultures
showed no significant bacteria, but the urine culture yielded yeast-like
organism. A CRP rose to 135.3 mg/L on April 7. Thus doripenem and
fluconazole were used. Then condition was stable and she was discharged to
a nursing home on April 14. On June 19, 2014, she returned with a fever of
38C. Urine routine showed WBC, 50-99/HPF; leukocyte esterase 3+ and
bacilli 3+. Co-amoxiclav was used for 7 days. The urine yielded imipenem-
resistant K. pneumoniae (IRKP), only susceptible to amikacin, gentamicin,
tigecycline and co-trimoxazole. On July 9, she had a fever of 38.1C. Urine
showed pyuria and IRKP, additionally resistant to tigecycline. Co-trimoxa-
zole was used for 7 days and eradicated the IRKP. PCR for blaKPC in the
plasmid of the IRKP isolates and DNA sequencing confirmed blaKPC-17 in 1st
IRKP and a new variant blaKPC-22 (GenBank acc no. KM379100) in 2nd IRKP.
Conclusions: We report two nursing home-acquired blaKPC-17- and blaKPC-22-
harboring IRKP isolates. Clinicians should be alert to IRKP, which may be a
KPC variant.PS 2-333
FIRST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV)
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Middle East Respiratory Syndrome (MERS) is a viral respiratory illness caused
by a coronavirus called MERS-CoV. It was first reported in Saudi Arabia in
2012 and has since spread to various Middle Eastern, European, North African
and Asian countries. In this case study, we report a 54-year-old man who
became the first laboratory-confirmed case of MERS-CoV infection in
Malaysia, as well as in Asia (outside Middle East), and also the first death
in this region due to the infection. He had underlying diabetes mellitus,
complaining of cough, fever and shortness of breath for 2 days with recent
visit to Middle East. Chest radiograph show a consolidation at the right
midzone. Blood investigations showed a normal haemoglobin and white cell
count with platelet 127 000/mm3, creatinine 132 micromol/L, urea 11
mmol/L, CK 935 mmol/L, ALT 62 mmol/L and AST 145 mmol/L. He was
started on intravenous Amoxycillin-Clavulanate acid, oral Erythromycin,
and oral Oseltamivir for pneumonia and throat swab was sent for MERS-
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tory failure. CTPA was done to rule out pulmonary embolism, which showed
no pulmonary embolism but bilateral gross consolidation, more on the right,
in keeping with an infective process. Antibiotics were changed to intrave-
nous Ceftriaxone and Azithromycin; however, there was continuous deterio-
ration and patient succumbed to his illness on day 4 of admission. His throat
swab was later traced back to be positive for MERS-CoV, while his sputum
was negative for bacterial cultures.PS 2-334
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Purpose: It is generally noted that patients with pneumonia from pandemic
H1N1 may have abnormal laboratory examination results, including elevated
creatine kinase (CK) levels in the previous literatures. We herein report a
similar case complicated with ARDS and rhabdomyolysis.
Case report
This 36-year-old woman was admitted to our emergent room with fever for 2
days. She was transferred to the ICU due to influenza A pneumonia with ARDS
and profound hypoxemia. Immediate endotracheal intubation was done and
Nitrogen oxide (NO) was used for profound hypoxemia. Prone position
ventilation was not attempted due to morbid obesity. Antibiotic therapy
with Tazozin, Cravit and Tamiflu was used. Dopamine was prescribed due to
refractory shock post resuscitation. However, no significant bacterial culture
result was obtained, except a positive PCR for Influenza A (H1N1). The PaO2/
FiO2 ratio remained < 200 mmHg, requiring the use of high PEEP, fully
sedation and muscle relaxant to maintain the oxygenation. However, fever
and shock persisted, hence, Cravit was shifted to Tygacil. The subsequent
follow-up blood culture was negative. Poor oxygenation hindered her from the
study of Computed Tomography. Oliguria with tea-colored urine was noted.
Marked elevation of CK total [7601 IU/L] and myoglobin [32890 mg/dL] were
noted. Rhabdomyolysis with acute renal failure was impressed, which was
probably related to H1N1 infection. After the treatment, the condition was
still worsening. Due to unstable blood pressure and severe metabolic acidosis
with oliguria, continuous veno-veno hemofiltration (CVVH) was commenced.
Then the patient finally expired due to progressive condition.
Conclusions: Although pneumonia and ARDS are the most common severe
complications of H1N1 infection. Rhabdomyolysis should be considered in
the evaluation of muscle symptoms associated with Influenza A (H1N1) Pneu-
monia, especially in critically ill patients. Timely extra-corporeal membrane
oxygenation may be helpful to survive the patients with life-threatening
Influenza infection.PS 2-335
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Purpose: Myroides species are widely distributed in nature, but clinical hu-
man infections by these organisms are extremely rare. We report herein pro-
longed outbreak of urinary tract infection by Myroides species.
Case report
A 63-year-old male of end stage renal disease, rheumatoid arthritis,
destroyed lung post operation, post tracheostomy suffered from conscious-
ness change and much sputum for five days. He was brought to emergency
department on November 17, 2014. Laboratory data shows leukocytosis
(WBC: 13,300/mL); bandemia (band: 5%); and C-reactive protein, 113 mg/
L. CXR showed almost whiteout of the right side destroyed lung with residual
alveolar, surgical clips and suture stitches left. Ceftazidime was given. Brain
CT showed mild communicating hydrocephalus and mixed acute and old
lacunar infarcts. He was admitted to intensive care unit (ICU). Emergent
ventilator support was used due to dyspnea and respiratory failure. Feverhappened. Sputum culture showed Pseudomonas aeruginosa and carbape-
nem-resistant Acinetobacter baumannii. Urine culture showed Myroides
species, susceptible to imipenem and piperacillin/tazobactum, but resistant
to ceftazidime and ciprofloxacin. Antibiotic was shifted to ceftazidime and
colistin. The patient condition improved gradually under medical treatment
and started weaning trial, but ABG showed CO2 retention. Owing to ventila-
tion dependence and improved condition, he was transferred to the RCW for
long-term care on November 27, 2014.
Conclusion
Serious and prolonged nosocomial outbreaks of urinary tract infections
caused by M. odoratimimus have been reported. Because multiresistance
was generally found in Myroides spp., empirical therapy was usually ineffec-
tive. We report a nosocomial urinary tract infection by Myroides spp.PS 2-336
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Purpose: The current Ebola virus (EBOV) epidemic highlights the need for
efficacious virucidal products. In Europe, EN 14476:2013/A1:2014 describes
the standard for determining virucidal activity. For the claim ‘virucidal
active against enveloped viruses for hygienic handrub and handwash’ the
Modified vaccinia virus Ankara (MVA) was introduced as reference virus in
2014. In the case of deadly EBOV, which is also an enveloped virus, the ac-
tivity needs to be proven.
The first aim of this study was to test the in-vitro efficacy of four povidone
iodine (PVPI) formulations containing 4% (BETADINE Skin Cleanser), 7.5%
(BETADINE Surgical Scrub), 10% (BETADINE Solution) PVPI and 3.2% PVPI
and 78% alcohol (BETASEPTIC). The second aim was to verify the claimed
concentration-contact-time values with EBOV.
Methods: In accordance with EN 14476 a standard suspension test was used
for testing against MVA and large-volume plating technology for testing
against EBOV to increase test sensitivity and to exclude potential after-ef-
fects. All products were tested under clean (0.3 g/l BSA) and dirty conditions
(3.0 g/l BSA + 3.0 ml/l erythrocytes) as interfering substance with an appli-
cation time of 15, 30, and 60 seconds for MVA and 15 seconds for EBOV. The
products were tested undiluted, 1:10 and 1:100 diluted against MVA and 1:10
diluted against EBOV.
Results: Viral titres of MVA and EBOV were reduced by >99.99% to >99.999%
under clean and dirty conditions with 15 seconds application.
Conclusions: All products showed excellent virucidal efficacy against EBOV
demonstrating the important role PVPI can play in the prevention and
limiting the spread of the Ebola disease. The proven efficacy against both
test viruses with 15 seconds application time is helpful information for
implementation of appropriate guidance to people exposed to EBOV and
confirms excellent virucidal efficacy of PVPI against enveloped viruses.
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Introduction: At the end of 2014, there were more than 28,000 reported
HIV-infected patients in Taiwan. Cytomegalovirus (CMV) infection, second-
ary to Pneumocystis jeroveci pneumonia and candidiasis, is the 3rd common
opportunistic infections in HIV-infected persons. This study aimed to explore
the relationships between CMV DNA quantitation and the severity of immune
compromised states among HIV patients.
Methods: Real time polymerase chain reaction (RT-PCR) was applied to
detect CMV DNA using COBAS AmpliPrep/COBAS TaqMan CMV assay (Roche
